| abstract |
A compound according to Formula I: wherein R 1 , L A , G A , R 2a , R 2b , R 3 , R 4 , R 5 , and R 6 are as described herein. The present invention relates to novel compounds according to Formula I that antagonize GPR84, a G-protein-coupled receptor that is involved in inflammatory conditions, and methods for the production of these novel compounds, pharmaceutical compositions comprising these compounds, and methods for the prevention and/or treatment of inflammatory conditions (for example inflammatory bowel diseases (IBD), rheumatoid arthritis, vasculitis), lung diseases (e.g., chronic obstructive pulmonary disease (COPD) and lung interstitial diseases (e.g., idiopathic pulmonary fibrosis (IPF))), neuroinflammatory conditions, infectious diseases, autoimmune diseases, endocrine and/or metabolic diseases, diseases involving impairment of immune cell functions, pain, neurodegenerative conditions, cardiovascular diseases, and/or leukemia by administering a compound of the invention. |